Medical Weight Loss for Bellflower, California Residents
Bellflower, California residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Important: Compounded semaglutide and tirzepatide are not FDA-approved and are not brand-identical. Eligibility and results vary.
Physician-supervised GLP-1 programs from $166/month, serving Bellflower through telehealth from our Costa Mesa, California clinic. Doctor review $119. Bilingual support available.
Why Bellflower Residents Choose New Hope Weight Loss
New Hope was designed around the way Bellflower residents actually live. You book your physician visit online, meet Dr. Anjmun Sharma by video, and if treatment makes sense fulfillment of your medication is considered only if a prescription is approved and the dispensing pharmacy confirms it can fulfill the prescription for the location where the patient will receive care; the pharmacy confirms packaging and shipping details before fulfillment. Everything runs through our Costa Mesa clinic by telehealth, so there is no local office to visit and no day off work required. The convenience is real, but the medical care behind it is the part we protect most.
From our Costa Mesa, California practice, we provide Bellflower with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication fulfillment is considered only if a prescription is approved and the dispensing pharmacy confirms it can fulfill the prescription for the location where the patient will receive care; the pharmacy confirms packaging and shipping details before fulfillment.
For patients in Bellflower, California, clinical fit and clinician availability require case-by-case review. We care for patients throughout downtown Bellflower and the Gateway Cities of southeast Los Angeles County. Your semaglutide or tirzepatide travels in insulated packaging confirmed by the dispensing pharmacy to keep it stable on the way to Bellflower, even on warm California afternoons.
Most people across Bellflower do not wait for an opening, they pick a time, meet Dr. Sharma by video, and can begin treatment only after medical review and any required pharmacy confirmation. We accept HSA and FSA cards for the $119 physician review, which lets many Bellflower patients use pre-tax dollars toward their care. California is our home state and our physical clinic sits in Costa Mesa, but we care for patients across the rest of the state by secure telehealth.
GLP-1 Weight Loss Programs Available
Semaglutide: the 90-Day Metabolic Reset
For context, STEP 1 reported an average 14.9% at 68 weeks for brand semaglutide. That result does not predict response to compounded semaglutide, which is not FDA-approved or brand-identical. Results vary, and the appropriate option depends on physician review, tolerability, access, and total cost.
Tirzepatide: the dual GLP-1 and GIP option
For context, SURMOUNT-1 reported an average 20.9% at 72 weeks for brand tirzepatide 15 mg. That result does not predict response to compounded tirzepatide, which is not FDA-approved or brand-identical. Results vary, and the appropriate option depends on physician review, tolerability, access, and total cost.
A $119 physician review is required up front. Medication billed separately. HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Bellflower
Getting started in Bellflower is simple, and you never have to leave home. Begin with a short intake quiz about your health history, weight goals, and any medications you take. Dr. Anjmun Sharma reviews your answers and meets you by secure video, after intake review, to talk through whether compounded semaglutide or tirzepatide is a reasonable fit. If she prescribes, medication fulfillment is considered only if a prescription is approved and the dispensing pharmacy confirms it can fulfill the prescription for the location where the patient will receive care; the pharmacy confirms packaging and shipping details before fulfillment. From there, your follow-up visits happen by video too, so dose checks and questions stay easy no matter where in California you live.
Frequently Asked Questions, Bellflower
Where is the New Hope Weight Loss location serving Bellflower?
The location serving Bellflower is our Costa Mesa, California clinic, which is our only physical site. We care for Bellflower, California patients through telehealth rather than a local office. Dr. Anjmun Sharma confirms your eligibility for a compounded GLP-1 plan during a private video consult.
Is remote care a real option for Bellflower patients?
It is the standard for Bellflower. The whole program runs on telehealth, so consults, follow-ups, and support happen wherever you are. When Dr. Sharma approves you, medication fulfillment is considered only if a prescription is approved and the dispensing pharmacy confirms it can fulfill the prescription for the location where the patient will receive care; the pharmacy confirms packaging and shipping details before fulfillment.
How much does a Bellflower patient pay overall?
The physician review is $119. Compounded semaglutide is offered from $166 monthly, or $499 for 90 days, and tirzepatide from $233 monthly. The medication is billed separately from the visit. We accept HSA, FSA, Klarna, and Affirm, and we apply any location-related charge must be confirmed in writing for Bellflower patients.
What areas of Bellflower do you serve?
We serve patients from across Bellflower by telehealth, including downtown Bellflower and the Gateway Cities of southeast Los Angeles County.
What support is there for side effects for Bellflower patients?
Dr. Sharma starts Bellflower patients at a low dose and titrates slowly to limit nausea and GI effects, and your health advisor is reachable between visits by phone, WhatsApp, or message to adjust the plan if needed.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Bellflower, California by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location.